| CAS: | 170809-51-5 | |
| 分子式: | C161H269N49O42 | |
| 分子量: | 3563.20 | |
| 英文名称: |
| |
| 用途: | Astressin是有效的促肾上腺皮质激素释放因子 (CRF) 拮抗剂。 |
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |||
| A881475 | MACKLIN | Astressin | ≥96% | 437元/1mg; 1444元/5mg; 2201元/10mg; | 咨询 | ||
储存:2-8℃ 状态:白色到灰白色固体 | |||||||
| HY-P0257 | MCE | Astressin,170809-51-5_MCE(MedChemExpress) | 1080元/1 mg; 2704元/5 mg; 4320元/10 mg; | 咨询 | |||
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。 AstressinMCE 国际站:Astressin 品牌:MedChemExpress (MCE) 货号:HY-P0257 CAS 号:170809-51-5 生物活性:应激素是一种强效的促肾上腺皮质激素释放因子(CRF)拮抗剂。 体外研究(In Vitro):Astressin has low affinity for the CRF binding protein and high affinity (Ki=2 nM) for the cloned pituitary receptor. Astressin shows high affinity for cloned human CRF-RA1 stably expressed in CHO cells and high potency to inhibit ACTH secretion[1]. MCE尚未独立确认这些方法的准确性。 仅供参考。 体内研究(In Vivo):Astressin is significantly more potent than any previously tested antagonist in reducing hypophyseal corticotropin (ACTH) secretion in stressed or adrenalectomized rats. Low doses of astressin (30 μg and 100 μg per kg) administered i.v. still produce a significant decrease in ACTH levels at 45 and 90 min, respectively[1]. Astressin significantly reverses the anxiogenic-like response induced by both social stress and ICV rat/humanCRF (r/hCRF) on the elevated plus-maze, but fails to block the effects of r/hCRF-induced locomotor activity in a familiar environment[2]. Intracerebroventricular infusion of the peptide both 30 min before and 10 min after seizures decreases damage in some hippocampal cell fields by as much as 84%, a magnitude of protection greater than reported for other CRF antagonists against other models of necrotic neuronal injury. Astressin protects even if administered only 10 min following excitotoxin exposure[3]. MCE尚未独立确认这些方法的准确性。 仅供参考。 分子量:3563.16 Formula:C161H269N49O42 性状:固体 颜色:White to off-white Sequence Shortening:DPhe-HLLREVLE-Nle-ARAEQLAQ-cyclo(EAHK)-NRKL-Nle-EII-NH2 运输条件:美国大陆地区的室温;其他地区可能有所不同。 储存方式:密封储存,避光防潮,氮气保护。粉末 -80°C 保存 2 年 Animal Administration [1]:Rats: Rat diet is supplemented with oranges, and their water contained 0.9% NaCl. They are equipped with indwelling jugular cannulae 48 h prior to the i.v. injection of either vehicle or astressin. Astressin is first diluted in sterile, distilled, apyrogenic water, and the pH is adjusted to 7.0. Further dilutions are made in 0.04 M phosphate buffer, pH 7.4, containing 0.1% bovine serum albumin and 0.01% ascorbic acid. Blood samples are obtained immediately before treatment, as well as 15-120 min later. Decanted plasma samples are frozen until assayed for ACTH concentrations[1]. MCE尚未独立确认这些方法的准确性。 仅供参考。 文献引用:MCE 顾客使用本产品发表 3 篇科研文献 提供质量检测报告:Data Sheet、SDS、COA、RP-HPLC、MS、元素分析报告、产品使用指南 产品活性:Astressin是有效的促肾上腺皮质激素释放因子 (CRF) 拮抗剂。 相关产品:Urocortin, human | MPTP hydrochloride | Y-27632 dihydrochloride | Y-27632 dihydrochloride | Haloperidol | Angiotensin II human | Haloperidol (Standard) | Calcitonin (human) | Olcegepant hydrochloride | Glucagon (1-29), bovine, human | TIP 39, Tuberoinfundibular Neuropeptide | Y-27632 dihydrochloride (Standard) 热门产品线:抑制剂 | 稳定性同位素标记物 | 脂质 | 糖类 Trending products:Inhibitors | Isotope-Labeled Compounds | Lipids | Saccharides MCE 抑制剂: MedChemExpress 信号通路产品覆盖细胞凋亡、自噬、细胞周期与 DNA 损伤、表观遗传、GPCR/G 蛋白、免疫与炎症、JAK/STAT、MAPK/ERK、膜转运体与离子通道、代谢酶与蛋白酶、神经信号、NF-κB、PI3K/Akt/mTOR、PROTAC、蛋白酪氨酸激酶/受体酪氨酸激酶、干细胞/Wnt、TGF-β/Smad 及维生素 D/核受体等研究方向,为肿瘤、感染、炎症与免疫、神经系统疾病、代谢性疾病、心血管疾病和内分泌研究提供多维度的产品选择,助力客户发表文献超 80,000 篇。 相关产品可根据具体情况提供化学结构、作用靶点、生物活性、纯度、溶解度、体内外研究信息、参考文献及质量分析报告 (COA)等资料。 客户发表文献: 参考文献: 品牌介绍:
| |||||||